Format
Sort by

Send to:

Choose Destination

Results: 4

Related Articles by Review for PubMed (Select 22184371)

1.

Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma.

Tarhini AA, Cherian J, Moschos SJ, Tawbi HA, Shuai Y, Gooding WE, Sander C, Kirkwood JM.

J Clin Oncol. 2012 Jan 20;30(3):322-8. doi: 10.1200/JCO.2011.37.5394. Epub 2011 Dec 19. Erratum in: J Clin Oncol. 2012 Nov 1;30(31):3903.

2.

Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors.

Minutilli E, Feliciani C.

Tumori. 2012 Mar-Apr;98(2):185-90. doi: 10.1700/1088.11928. Review.

PMID:
22677983
3.

Biochemotherapy in the treatment of metastatic melanoma in selected patients.

González Astorga B, Jiménez Rubiano B, Delgado Pérez JR, Valdivia Bautista J, Sánchez Toro C, González Flores E, Luque Caro R, Castellón Rubio V.

Clin Transl Oncol. 2009 Jun;11(6):382-6. Review.

PMID:
19531453
4.

Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha.

Vaishampayan U, Abrams J, Darrah D, Jones V, Mitchell MS.

Clin Cancer Res. 2002 Dec;8(12):3696-701. Review.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk